Palo Alto Investors LP
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of buying every stock this filer reported holding, rebalancing on each filing and indexed to the same start. Option positions cannot be bought this way and are left out.
Estimate. 13F holdings are quarter-lagged, so the clone rebalances about 45 days after each period end — when the filing becomes public — and it excludes option and short positions. It tracks 100% of reported value on average across 13 quarters. Past performance does not predict future results.
Portfolio Concentration
51 tracked positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Portfolio Trend
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 99.7% | $651,950,232 |
| Financial Services | 0.3% | $1,912,808 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ANNX | Annexon, Inc. | +563,898 | 2,948,090 | $16,332,418 | |
| ACAD | Acadia Pharmaceuticals Inc | +388,664 | 2,872,695 | $63,946,190 | |
| BCAX | Bicara Therapeutics Inc. | +251,833 | 550,408 | $10,947,615 | |
| TSHA | Taysha Gene Therapies, Inc. | +208,187 | 1,391,382 | $6,219,477 | |
| DYN | Dyne Therapeutics, Inc. | +180,775 | 1,652,972 | $29,968,382 | |
| MIRM | Mirum Pharmaceuticals, Inc. | +168,754 | 325,175 | $30,039,666 | |
| RARE | Ultragenyx Pharmaceutical Inc. | +135,201 | 596,495 | $12,496,570 | |
| TVTX | Travere Therapeutics, Inc. | +119,734 | 230,453 | $6,846,758 | |
| IRON | Disc Medicine, Inc. | +84,263 | 401,719 | $25,685,912 | |
| SNDX | Syndax Pharmaceuticals Inc | +70,479 | 864,986 | $20,206,072 | |
| CDNA | CareDx, Inc. | +53,650 | 531,870 | $9,233,263 | |
| ACRS | Aclaris Therapeutics, Inc. | +46,590 | 1,613,430 | $6,050,362 | |
| PTCT | Ptc Therapeutics, Inc. | +17,691 | 921,607 | $62,789,084 | |
| STOK | Stoke Therapeutics, Inc. | +12,609 | 84,631 | $2,755,585 | |
| UTHR | UNITED THERAPEUTICS Corp | +4,623 | 62,809 | $37,244,480 | |
| CAPR | Capricor Therapeutics, Inc. | +3,459 | 229,763 | $6,984,795 | |
| AGIO | Agios Pharmaceuticals, Inc. | +1,102 | 213,601 | $7,226,121 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| FOLD | AMICUS THERAPEUTICS, INC. | −4,092,722 | 1,113,045 | $16,094,630 | |
| CMPX | Compass Therapeutics, Inc. | −1,017,915 | 1,514,504 | $8,011,726 | |
| IOVA | Iovance Biotherapeutics, Inc. | −767,113 | 6,349,563 | $22,286,966 | |
| DNLI | Denali Therapeutics Inc. | −406,657 | 234,582 | $4,503,974 | |
| PRTA | Prothena Corp Public Ltd Co | −111,942 | 1,208,568 | $11,747,280 | |
| INSM | INSMED Inc | −74,213 | 415,269 | $67,904,786 | |
| ALDX | Aldeyra Therapeutics, Inc. | −69,756 | 155,709 | $263,148 | |
| BMRN | Biomarin Pharmaceutical Inc | −61,074 | 685,182 | $38,705,931 | |
| ANAB | Anaptysbio, Inc | −51,871 | 638,161 | $35,392,377 | |
| EHTH | eHealth, Inc. | −48,632 | 1,482,797 | $1,912,808 | |
| XENE | Xenon Pharmaceuticals Inc. | −45,174 | 51,345 | $2,985,711 | |
| BIIB | Biogen Inc. | −42,852 | 140,719 | $25,798,014 | |
| NUVB | Nuvation Bio Inc. | −29,233 | 508,846 | $2,182,949 | |
| PYXS | Pyxis Oncology, Inc. | −26,911 | 1,010,510 | $1,475,344 | |
| BCYC | Bicycle Therapeutics PLC | −19,181 | 201,890 | $936,769 | |
| NVCR | NovoCure Ltd | −18,525 | 1,280,439 | $13,956,785 | |
| CRSP | CRISPR Therapeutics AG | −1,621 | 39,605 | $1,884,009 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| CLDX | Celldex Therapeutics, Inc. | 296,408 | $9,402,061 | |
| CYTK | Cytokinetics Inc | 32,195 | $2,121,972 | |
| VSTM | Verastem, Inc. | 246,093 | $1,304,292 | |
| MDGL | Madrigal Pharmaceuticals, Inc. | 1,787 | $935,440 | |
| XERS | Xeris Biopharma Holdings, Inc. | 104,410 | $605,578 | |
| No positions match the current search. | ||||
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| INSM |
INSMED Inc
Healthcare
|
Reduced | 415,269 | $67,904,786 | 10.39% | |
| ACAD |
Acadia Pharmaceuticals Inc
Healthcare
|
Added | 2,872,695 | $63,946,190 | 9.78% | |
| PTCT |
Ptc Therapeutics, Inc.
Healthcare
|
Added | 921,607 | $62,789,084 | 9.60% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Reduced | 685,182 | $38,705,931 | 5.92% | |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
Added | 62,809 | $37,244,480 | 5.70% | |
| ANAB |
Anaptysbio, Inc
Healthcare
|
Reduced | 638,161 | $35,392,377 | 5.41% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
Added | 325,175 | $30,039,666 | 4.59% | |
| DYN |
Dyne Therapeutics, Inc.
Healthcare
|
Added | 1,652,972 | $29,968,382 | 4.58% | |
| BIIB |
Biogen Inc.
Healthcare
|
Reduced | 140,719 | $25,798,014 | 3.95% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Added | 401,719 | $25,685,912 | 3.93% | |
| IOVA |
Iovance Biotherapeutics, Inc.
Healthcare
|
Reduced | 6,349,563 | $22,286,966 | 3.41% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Added | 864,986 | $20,206,072 | 3.09% | |
| ANNX |
Annexon, Inc.
Healthcare
|
Added | 2,948,090 | $16,332,418 | 2.50% | |
| FOLD |
AMICUS THERAPEUTICS, INC.
Healthcare
|
Reduced | 1,113,045 | $16,094,630 | 2.46% | |
| NVCR |
NovoCure Ltd
Healthcare
|
Reduced | 1,280,439 | $13,956,785 | 2.13% | |
| RARE |
Ultragenyx Pharmaceutical Inc.
Healthcare
|
Added | 596,495 | $12,496,570 | 1.91% | |
| PRTA |
Prothena Corp Public Ltd Co
Healthcare
|
Reduced | 1,208,568 | $11,747,280 | 1.80% | |
| BCAX |
Bicara Therapeutics Inc.
Healthcare
|
Added | 550,408 | $10,947,615 | 1.67% | |
| CLDX |
Celldex Therapeutics, Inc.
Healthcare
|
NEW | 296,408 | $9,402,061 | 1.44% | |
| CDNA |
CareDx, Inc.
Healthcare
|
Added | 531,870 | $9,233,263 | 1.41% | |
| ALKS |
Alkermes plc.
Healthcare
|
Held | 242,560 | $8,576,921 | 1.31% | |
| CMPX |
Compass Therapeutics, Inc.
Healthcare
|
Reduced | 1,514,504 | $8,011,726 | 1.23% | |
| AGIO |
Agios Pharmaceuticals, Inc.
Healthcare
|
Added | 213,601 | $7,226,121 | 1.11% | |
| ALGN |
Align Technology Inc
Healthcare
|
Held | 41,520 | $7,117,773 | 1.09% | |
| CAPR |
Capricor Therapeutics, Inc.
Healthcare
|
Added | 229,763 | $6,984,795 | 1.07% | |
| TVTX |
Travere Therapeutics, Inc.
Healthcare
|
Added | 230,453 | $6,846,758 | 1.05% | |
| TSHA |
Taysha Gene Therapies, Inc.
Healthcare
|
Added | 1,391,382 | $6,219,477 | 0.95% | |
| ACRS |
Aclaris Therapeutics, Inc.
Healthcare
|
Added | 1,613,430 | $6,050,362 | 0.93% | |
| DNLI |
Denali Therapeutics Inc.
Healthcare
|
Reduced | 234,582 | $4,503,974 | 0.69% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Reduced | 51,345 | $2,985,711 | 0.46% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
Held | 59,985 | $2,942,264 | 0.45% | |
| STOK |
Stoke Therapeutics, Inc.
Healthcare
|
Added | 84,631 | $2,755,585 | 0.42% | |
| EW |
Edwards Lifesciences Corp
Healthcare
|
Held | 33,640 | $2,693,891 | 0.41% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
Held | 18,117 | $2,386,733 | 0.37% | |
| NUVB |
Nuvation Bio Inc.
Healthcare
|
Reduced | 508,846 | $2,182,949 | 0.33% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
NEW | 32,195 | $2,121,972 | 0.32% | |
| EHTH |
eHealth, Inc.
Financial Services
|
Reduced | 1,482,797 | $1,912,808 | 0.29% | |
| CRSP |
CRISPR Therapeutics AG
Healthcare
|
Reduced | 39,605 | $1,884,009 | 0.29% | |
| BNTX |
BioNTech SE
Healthcare
|
Held | 19,614 | $1,743,292 | 0.27% | |
| PYXS |
Pyxis Oncology, Inc.
Healthcare
|
Reduced | 1,010,510 | $1,475,344 | 0.23% | |
| VSTM |
Verastem, Inc.
Healthcare
|
NEW | 246,093 | $1,304,292 | 0.20% | |
| BCYC |
Bicycle Therapeutics PLC
Healthcare
|
Reduced | 201,890 | $936,769 | 0.14% | |
| MDGL |
Madrigal Pharmaceuticals, Inc.
Healthcare
|
NEW | 1,787 | $935,440 | 0.14% | |
| HUM |
Humana Inc
Healthcare
|
Held | 3,985 | $690,959 | 0.11% | |
| CMPS |
COMPASS Pathways plc
Healthcare
|
Held | 115,616 | $639,356 | 0.10% | |
| XERS |
Xeris Biopharma Holdings, Inc.
Healthcare
|
NEW | 104,410 | $605,578 | 0.09% | |
| ABEO |
Abeona Therapeutics Inc.
Healthcare
|
Held | 108,865 | $487,715 | 0.07% | |
| INSP |
Inspire Medical Systems, Inc.
Healthcare
|
Held | 8,772 | $452,459 | 0.07% | |
| URGN |
UroGen Pharma Ltd.
Healthcare
|
Held | 24,500 | $440,510 | 0.07% | |
| PRQR |
ProQR Therapeutics N.V.
Healthcare
|
Held | 188,807 | $305,867 | 0.05% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.